← FDA Drug Approvals (Drugs@FDA)

IMMGOLIS

BLA · Biologics License Application · Sponsor: ACCORD BIOPHARMA INC. · Approved 2026-05-15

Drug application

FDA Application #

BLA761452

Application type

Biologics License Application

Brand name

IMMGOLIS

Generic name

Golimumab-Sldi

Active ingredients

GOLIMUMAB-SLDI

Dosage form

INJECTION

Route

SOLUTION

Marketing status

Prescription

Sponsor

ACCORD BIOPHARMA INC.

First approval

2026-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown